|Articles|August 2, 2012
- Pharmaceutical Technology-08-02-2012
- Volume 36
- Issue 8
Pharmaceutical Technology, August 2012 Issue (PDF)
Measuring Growth - Big Pharma's Manufacturing Investments
Advertisement
Articles in this issue
almost 14 years ago
Q&A with Babu Padmanabhan, STEER Engineeringalmost 14 years ago
The Truth About Drug Shortagesalmost 14 years ago
Report from Japanalmost 14 years ago
Pharmaceutical-Based Cargo Security and Theft Preventionalmost 14 years ago
Scaling up API Synthesesalmost 14 years ago
Small Changes, System-Wide Impactalmost 14 years ago
Measuring Growth in Big Pharma's Manufacturing Investmentalmost 14 years ago
Gauging Biopharm Outsourcingalmost 14 years ago
In the Spotlight August 2012almost 14 years ago
FDA User-Fee Legislation Sets Stage for ChangeAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
Lonza Increases HPAPI Production at Visp Facility
5